Results 121 to 130 of about 101,747 (197)

PF4‐associated immune thrombocytopenia and thrombosis (PITT)—More than heparin and vaccines

British Journal of Haematology, EarlyView.
A young woman presented with portal vein thrombosis and thrombocytopenia and developed further extensive thrombosis following treatment with heparin. Despite no previous heparin exposure, she was found to be strongly positive for anti‐platelet factor 4 (PF4) antibodies.
Michael Makris
wiley   +1 more source

Evidence for a Causal Association Between Human Cytomegalovirus Infection and Chronic Back Pain: A One-Sample Mendelian Randomization Study. [PDF]

JOR Spine
Naeini MK, Freidin MB, Smith IG, Ward S, Williams FMK.   +4 more
europepmc   +1 more source

The progression of multiple myeloma is regulated by LILRB1 via the GATA2–SAGE1 pathway

British Journal of Haematology, EarlyView.
Summary Multiple myeloma (MM) is a haematological malignancy characterized by the clonal expansion of plasma cells within the bone marrow, thus resulting in the overproduction of monoclonal immunoglobulins. Despite the availability of various immunotherapeutic strategies, patient survival rates remain disappointingly low, thus underscoring the need for
Chiqi Chen, Xuanyi Zhou, Liyuan Cao, Wenqian Yang, Lietao Weng, Jin Yuan, Wen Zhou, Zhuo Yu, Junke Zheng   +8 more
wiley   +1 more source

Seroprevalent study of cytomegalovirus infection in the regions of Jharkhand. [PDF]

J Family Med Prim Care
Sundi A, Roopa N, Gupta P, Irfan S, Kar TK.   +4 more
europepmc   +1 more source

Ultrasound features of congenital cytomegalovirus infection in the first trimester: A case report.

World J Clin Cases
Chen XL, Zhang LQ, Bai LL.
europepmc   +1 more source

Neonatal T cells unleash innate powers to combat congenital cytomegalovirus infection. [PDF]

J Clin Invest
Grassmann S.
europepmc   +1 more source

Copanlisib in combination with rituximab and bendamustine for transplant‐ineligible relapsed/refractory diffuse large B‐cell lymphoma patients: Results from the phase II multicentre FIL Copa‐BR trial from Fondazione Italiana Linfomi (FIL)

British Journal of Haematology, EarlyView.
A phase II, single‐arm, multicentre trial was conducted by Fondazione Italiana Linfomi (FIL) to investigate the combination of copanlisib plus rituximab and bendamustine (copa‐BR) in transplant‐ and chimeric antigen receptor (CAR)‐T‐ineligible relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL). Thirty‐seven patients were enrolled.
Mattia Novo, Pio Manlio Mirko Frascione, Alessia Castellino, Luigi Marcheselli, Samantha Deianira Dattoli, Margherita Vannucchi, Delia Rota‐Scalabrini, Alessandra Tucci, Guido Gini, Giuseppe Tarantini, Donato Mannina, Annalisa Arcari, Arcangelo Liso, Elisabetta Scarpa, Dario Marino, Michele Spina, Ausilia Gorgone, Nicola Di Renzo, Salvatrice Mancuso, Luigi Petrucci, Agostino Tafuri, Barbara Botto, Francesca Bonello, Elisa Santambrogio, Umberto Vitolo   +24 more
wiley   +1 more source

CMV proctitis mimicking a rectal tumor

ANZ Journal of Surgery, EarlyView.
Wei Ming Ong, Perry Lindsay, Suat Chin Ng, David Machet, Vinna An   +4 more
wiley   +1 more source